Logo Image
|Articles|July 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-07-01-2001
  • Volume 0
  • Issue 0

Pharmacies: OTC Price Wars

Author(s)Kevin Gopal

London, United Kingdom-The UK OTC trade association supports the Community Pharmacy Action Group (CPAG) in its decision to withdraw a court case regarding the price-fixing of OTC drugs after the judge said there was little evidence that abolition of price maintenance would harm community pharmacists. The withdrawal brings an end to a long-running court battle pitting the pharmaceutical industry against an equally powerful corporate enemy, the supermarkets.

Articles in this issue

over 25 years ago

One Disease at a Time

over 25 years ago

Overview of the Industry: A World of Opportunities

over 25 years ago

The Power Shift

over 25 years ago

A Giant Stumbles

over 25 years ago

Overruled: No More Dual Pricing

over 25 years ago

Submerged

over 25 years ago

Generic Threat

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Tecentriq
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Read more
Naoki Okamura: Post-Patent Plan and Purpose
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.
Read more